Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · June 14, 2023

Efficacy of Apatinib Plus Etoposide in Pretreated Patients With Advanced TNBC

BMC Cancer

 

Additional Info

BMC Cancer
Apatinib plus etoposide in pretreated patients with advanced triple-negative breast cancer: a phase II trial
BMC Cancer 2023 May 19;23(1)463, M Cao, H Lu, S Yan, H Pang, L Sun, C Li, X Chen, W Liu, J Hu, J Huang, Y Xing, N Zhang, Y Chen, T He, D Zhao, Y Sun, L Zhao, X Liu, L Cai

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading